Transsphenoidal hypophysectomy — surgical removal of a pituitary tumour — offers the possibility of cure for pituitary-dependent Cushing's disease in dogs, with welfare implications distinct from lifelong medical management.
The welfare comparison between lifelong medical management and surgical cure of PDH is nuanced. Medical management with trilostane effectively controls signs but requires daily medication, regular monitoring, and does not prevent tumour growth — dogs with macroadenomas may develop neurological signs from tumour expansion. Successful hypophysectomy achieves true cure, eliminating the need for ongoing adrenocortical suppressant medication and allowing full return to normal adrenal physiology. The surgical risk is real and requires an honest informed consent discussion. For dogs with microadenomas and appropriate surgical candidacy, the welfare benefit of cure versus indefinite medical management can be substantial. Access to specialist centres capable of performing this surgery is limited, making referral pathways an important welfare infrastructure issue.